Trending: Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
26 Setembro 2022 - 11:48AM
Dow Jones News
10:18 ET -- Pfizer Inc. and BioNTech SE are two of the most
talked about companies in the U.S. across all news items in the
last 12 hours, according to Factiva data. The vaccine partners have
asked the U.S. Food and Drug Administration to approve the use of
their updated Covid-19 booster, which targets the original strain
and the fast-spreading Omicron variants, in children ages 5 through
11. An FDA decision could come before the end of the year. Dow
Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
September 26, 2022 10:33 ET (14:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024